How pharmacist prescribing can alleviate health-care system pressures

prescribtion

Starting next January, pharmacists in Ontario will be able to prescribe medications to treat patients for certain minor ailments. This expanding scope of work is a natural evolution of the wider services pharmacists across the province have been performing since COVID-19 began to stretch the health-care system. They have taken on COVID-19 testing, vaccinations, and the distribution of antiviral medications like Paxlovid.

Continue reading

10 Medications That Are Dangerous to Stop Abruptly

Medications

“Can I just stop my medication?” This is one question healthcare providers (HCPs) hear often. And it has a complicated answer.

Some medications can be dangerous to stop abruptly. Not only could your medical condition get worse, but you could also have dangerous side effects. And with some medications like antidepressants, stopping cold turkey is riskier the longer you’ve been taking them.

Some medications need to be gradually lowered (tapered). Your HCP can help you make a taper plan. In other words, they’ll help you slowly lower your dose over a period of time.

Continue reading

HOW CAN MEDCHOICE PHARMACY SAVE YOUR HEALTH BENEFIT PLAN?

saving on medications
saving on medications

 

✔✍- SAVE on cost

  • Filling 3 months’ supplies saves you 66.6 percent out of pocket.

✔✍- SAVE on gas

  • With Delivery across Canada,we deliver to your doorstep.

✔✍- SAVE on time

  • You don’t stand in-line to get your prescriptions filled.

✔✍- SAVE on Safety

  • by placing your orders from the convenience of their own home.

 

Video consultation is available remotely and discreetly.

 

Evusheld: first product approved for pre-exposure prophylaxis of COVID-19

Prophylaxis of COVID-19

The FDA has issued an Emergency Use Authorization (EUA) for the investigational long-acting monoclonal antibodies tixagevimab and cilgavimab (Evusheld – AstraZeneca) to be administered concomitantly by IM injection for pre-exposure prophylaxis of COVID-19 in persons ≥12 years old who weigh ≥40 kg and have either a history of severe allergy that prevents their vaccination against COVID-19 or moderate or severe immune compromise (see Box).

Continue reading